{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T17:56:27Z","timestamp":1790963787768,"version":"4.1.0"},"reference-count":45,"publisher":"American Society of Hematology","issue":"6","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2012,2,9]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Bortezomib, a therapeutic agent for multiple myeloma (MM) and mantle cell lymphoma, suppresses proteosomal degradation leading to substantial changes in cellular transcriptional programs and ultimately resulting in apoptosis. Transcriptional regulators required for bortezomib-induced apoptosis in MM cells are largely unknown. Using gene expression profiling, we identified 36 transcription factors that displayed altered expression in MM cells treated with bortezomib. Analysis of a publically available database identified Kruppel-like family factor 9 (KLF9) as the only transcription factor with significantly higher basal expression in MM cells from patients who responded to bortezomib compared with nonresponders. We demonstrated that KLF9 in cultured MM cells was up-regulated by bortezomib; however, it was not through the induction of endoplasmic reticulum stress. Instead, KLF9 levels correlated with bortezomib-dependent inhibition of histone deacetylases (HDAC) and were increased by the HDAC inhibitor LBH589 (panobinostat). Furthermore, bortezomib induced binding of endogenous KLF9 to the promoter of the proapoptotic gene NOXA. Importantly, KLF9 knockdown impaired NOXA up-regulation and apoptosis caused by bortezomib, LBH589, or a combination of theses drugs, whereas KLF9 overexpression induced apoptosis that was partially NOXA-dependent. Our data identify KLF9 as a novel and potentially clinically relevant transcriptional regulator of drug-induced apoptosis in MM cells.<\/jats:p>","DOI":"10.1182\/blood-2011-04-346676","type":"journal-article","created":{"date-parts":[[2011,12,6]],"date-time":"2011-12-06T07:08:55Z","timestamp":1323155335000},"page":"1450-1458","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":58,"title":["KLF9 is a novel transcriptional regulator of bortezomib- and LBH589-induced apoptosis in multiple myeloma cells"],"prefix":"10.1182","volume":"119","author":[{"given":"Sudha","family":"Mannava","sequence":"first","affiliation":[{"name":"Departments of Cell Stress Biology,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"DaZhong","family":"Zhuang","sequence":"additional","affiliation":[{"name":"Departments of Cell Stress Biology,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jayakumar R.","family":"Nair","sequence":"additional","affiliation":[{"name":"Immunology, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajat","family":"Bansal","sequence":"additional","affiliation":[{"name":"Departments of Cell Stress Biology,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph A.","family":"Wawrzyniak","sequence":"additional","affiliation":[{"name":"Departments of Cell Stress Biology,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shoshanna N.","family":"Zucker","sequence":"additional","affiliation":[{"name":"Departments of Cell Stress Biology,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily E.","family":"Fink","sequence":"additional","affiliation":[{"name":"Departments of Cell Stress Biology,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kalyana C.","family":"Moparthy","sequence":"additional","affiliation":[{"name":"Departments of Cell Stress Biology,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiang","family":"Hu","sequence":"additional","affiliation":[{"name":"Biostatistics, Roswell Park Cancer Institute, Buffalo, NY; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Song","family":"Liu","sequence":"additional","affiliation":[{"name":"Biostatistics, Roswell Park Cancer Institute, Buffalo, NY; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lawrence H.","family":"Boise","sequence":"additional","affiliation":[{"name":"Department of Hematology and Medical Oncology, Emory University School of Medicine and the Winship Cancer Institute, Atlanta, GA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelvin P.","family":"Lee","sequence":"additional","affiliation":[{"name":"Immunology, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mikhail A.","family":"Nikiforov","sequence":"additional","affiliation":[{"name":"Departments of Cell Stress Biology,"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"issue":"1","key":"2019111807454423700_B1","first-page":"65","article-title":"Bortezomib therapy for myeloma.","volume":"3","author":"Anderson","year":"2004","journal-title":"Curr Hematol Rep"},{"issue":"1","key":"2019111807454423700_B2","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3322\/canjclin.50.1.7","article-title":"Cancer statistics, 2000.","volume":"50","author":"Greenlee","year":"2000","journal-title":"CA Cancer J Clin"},{"issue":"5","key":"2019111807454423700_B3","doi-asserted-by":"crossref","first-page":"2516","DOI":"10.1182\/blood-2007-10-116129","article-title":"Improved survival in multiple myeloma and the impact of novel therapies.","volume":"111","author":"Kumar","year":"2008","journal-title":"Blood"},{"issue":"9686","key":"2019111807454423700_B4","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/S0140-6736(09)60221-X","article-title":"Multiple myeloma.","volume":"374","author":"Raab","year":"2009","journal-title":"Lancet"},{"issue":"1","key":"2019111807454423700_B5","doi-asserted-by":"crossref","first-page":"34","DOI":"10.3109\/10428194.2010.531409","article-title":"Novel agents improve survival of transplant patients with multiple myeloma including those with high-risk disease defined by early relapse (< 12 months).","volume":"52","author":"Venner","year":"2011","journal-title":"Leuk Lymphoma"},{"issue":"9","key":"2019111807454423700_B6","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1038\/sj.onc.1210744","article-title":"BCL-2 family regulation by the 20S proteasome inhibitor bortezomib.","volume":"27","author":"Fennell","year":"2008","journal-title":"Oncogene"},{"issue":"14","key":"2019111807454423700_B7","doi-asserted-by":"crossref","first-page":"6282","DOI":"10.1158\/0008-5472.CAN-05-0676","article-title":"Proteasome inhibitors trigger NOXA-mediated apoptosis in melanoma and myeloma cells.","volume":"65","author":"Qin","year":"2005","journal-title":"Cancer Res"},{"issue":"14","key":"2019111807454423700_B8","doi-asserted-by":"crossref","first-page":"6294","DOI":"10.1158\/0008-5472.CAN-05-0686","article-title":"Differential regulation of noxa in normal melanocytes and melanoma cells by proteasome inhibition: therapeutic implications.","volume":"65","author":"Fern\u00e1ndez","year":"2005","journal-title":"Cancer Res"},{"issue":"11","key":"2019111807454423700_B9","doi-asserted-by":"crossref","first-page":"5418","DOI":"10.1158\/0008-5472.CAN-06-4322","article-title":"Noxa up-regulation and Mcl-1 cleavage are associated to apoptosis induction by bortezomib in multiple myeloma.","volume":"67","author":"Gomez-Bougie","year":"2007","journal-title":"Cancer Res"},{"key":"2019111807454423700_B10","doi-asserted-by":"crossref","first-page":"6192","DOI":"10.1074\/jbc.M610643200","article-title":"Rapid turnover of Mcl-1 couples translation to cell survival and apoptosis.","volume":"282","author":"Adams","year":"2007","journal-title":"J Biol Chem"},{"key":"2019111807454423700_B11","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.critrevonc.2008.10.004","article-title":"Involvement of BH3-only proteins in hematologic malignancies.","volume":"71","author":"Kuroda","year":"2009","journal-title":"Crit Rev Oncol Hematol"},{"issue":"21","key":"2019111807454423700_B12","doi-asserted-by":"crossref","first-page":"6050","DOI":"10.1111\/j.1742-4658.2009.07329.x","article-title":"Apoptosis and autophagy: BIM as a mediator of tumour cell death in response to oncogene-targeted therapeutics.","volume":"276","author":"Gillings","year":"2009","journal-title":"FEBS J"},{"issue":"49","key":"2019111807454423700_B13","doi-asserted-by":"crossref","first-page":"19488","DOI":"10.1073\/pnas.0708380104","article-title":"Tumor cell-selective regulation of NOXA by c-MYC in response to proteasome inhibition.","volume":"104","author":"Nikiforov","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"11","key":"2019111807454423700_B14","doi-asserted-by":"crossref","first-page":"4318","DOI":"10.1158\/0008-5472.CAN-09-4428","article-title":"Genome-wide siRNA screen for modulators of cell death induced by proteasome inhibitor bortezomib.","volume":"70","author":"Chen","year":"2010","journal-title":"Cancer Res"},{"issue":"7","key":"2019111807454423700_B15","doi-asserted-by":"crossref","first-page":"2200","DOI":"10.1073\/pnas.0807611106","article-title":"ERAD inhibitors integrate ER stress with an epigenetic mechanism to activate BH3-only protein NOXA in cancer cells.","volume":"106","author":"Wang","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"9","key":"2019111807454423700_B16","doi-asserted-by":"crossref","first-page":"6091","DOI":"10.1074\/jbc.M109.014092","article-title":"Regulation of endoplasmic reticulum stress-induced cell death by ATF4 in neuroectodermal tumor cells.","volume":"285","author":"Armstrong","year":"2010","journal-title":"J Biol Chem"},{"issue":"1","key":"2019111807454423700_B17","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/s10495-005-3088-0","article-title":"Role of the unfolded protein response in cell death.","volume":"11","author":"Kim","year":"2006","journal-title":"Apoptosis"},{"issue":"10","key":"2019111807454423700_B18","doi-asserted-by":"crossref","first-page":"4415","DOI":"10.1158\/0008-5472.CAN-08-2839","article-title":"The role of ATF4 stabilization and autophagy in resistance of breast cancer cells treated with bortezomib.","volume":"69","author":"Milani","year":"2009","journal-title":"Cancer Res"},{"issue":"7","key":"2019111807454423700_B19","first-page":"3071","article-title":"The proteasome inhibitor PS-341 inhibits growth, induces apoptosis, and overcomes drug resistance in human multiple myeloma cells.","volume":"61","author":"Hideshima","year":"2001","journal-title":"Cancer Res"},{"issue":"3","key":"2019111807454423700_B20","first-page":"1136","article-title":"The proteasome inhibitor PS-341 markedly enhances sensitivity of multiple myeloma tumor cells to chemotherapeutic agents.","volume":"9","author":"Ma","year":"2003","journal-title":"Clin Cancer Res"},{"issue":"19","key":"2019111807454423700_B21","doi-asserted-by":"crossref","first-page":"16639","DOI":"10.1074\/jbc.M200360200","article-title":"NF-kappa B as a therapeutic target in multiple myeloma.","volume":"277","author":"Hideshima","year":"2002","journal-title":"J Biol Chem"},{"issue":"12","key":"2019111807454423700_B22","doi-asserted-by":"crossref","first-page":"4907","DOI":"10.1182\/blood-2005-08-3531","article-title":"Proteasome inhibitors induce a terminal unfolded protein response in multiple myeloma cells.","volume":"107","author":"Obeng","year":"2006","journal-title":"Blood"},{"issue":"4","key":"2019111807454423700_B23","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1080\/10428190801910912","article-title":"Noxa mediates bortezomib induced apoptosis in both sensitive and intrinsically resistant mantle cell lymphoma cells and this effect is independent of constitutive activity of the AKT and NF-kappaB pathways.","volume":"49","author":"Rizzatti","year":"2008","journal-title":"Leuk Lymphoma"},{"issue":"7","key":"2019111807454423700_B24","doi-asserted-by":"crossref","first-page":"2917","DOI":"10.1182\/blood-2007-12-130823","article-title":"Myc regulates aggresome formation, the induction of Noxa, and apoptosis in response to the combination of bortezomib and SAHA.","volume":"112","author":"Nawrocki","year":"2008","journal-title":"Blood"},{"issue":"9","key":"2019111807454423700_B25","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1007\/s001090050258","article-title":"Early growth response factor 1: a pleiotropic mediator of inducible gene expression.","volume":"76","author":"Khachigian","year":"1998","journal-title":"J Mol Med"},{"issue":"1","key":"2019111807454423700_B26","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1182\/blood-2009-03-210526","article-title":"Identification of early growth response protein 1 (EGR-1) as a novel target for JUN-induced apoptosis in multiple myeloma.","volume":"115","author":"Chen","year":"2010","journal-title":"Blood"},{"issue":"2","key":"2019111807454423700_B27","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1111\/j.1365-2141.2006.06132.x","article-title":"Gene expression analysis of B-lymphoma cells resistant and sensitive to bortezomib.","volume":"134","author":"Shringarpure","year":"2006","journal-title":"Br J Haematol"},{"issue":"8","key":"2019111807454423700_B28","doi-asserted-by":"crossref","first-page":"3177","DOI":"10.1182\/blood-2006-09-044974","article-title":"Gene expression profiling and correlation with outcome in clinical trials of the proteasome inhibitor bortezomib.","volume":"109","author":"Mulligan","year":"2007","journal-title":"Blood"},{"issue":"3","key":"2019111807454423700_B29","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1095\/biolreprod.105.041855","article-title":"Null mutation of Kruppel-like factor9\/basic transcription element binding protein-1 alters peri-implantation uterine development in mice.","volume":"73","author":"Velarde","year":"2005","journal-title":"Biol Reprod"},{"issue":"6","key":"2019111807454423700_B30","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1095\/biolreprod.107.065821","article-title":"Delayed parturition and altered myometrial progesterone receptor isoform A expression in mice null for Kr\u00fcppel-like factor 9.","volume":"78","author":"Zeng","year":"2008","journal-title":"Biol Reprod"},{"issue":"6","key":"2019111807454423700_B31","doi-asserted-by":"crossref","first-page":"G1757","DOI":"10.1152\/ajpgi.00013.2007","article-title":"Dysregulation of intestinal crypt cell proliferation and villus cell migration in mice lacking Kruppel-like factor 9.","volume":"292","author":"Simmen","year":"2007","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"issue":"4","key":"2019111807454423700_B32","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1210\/en.2008-1441","article-title":"Stressor and glucocorticoid-dependent induction of the immediate early gene kruppel-like factor 9: implications for neural development and plasticity.","volume":"150","author":"Bonett","year":"2009","journal-title":"Endocrinology"},{"issue":"33","key":"2019111807454423700_B33","doi-asserted-by":"crossref","first-page":"13420","DOI":"10.1073\/pnas.0703872104","article-title":"Decreased expression of Kruppel-like factors in memory B cells induces the rapid response typical of secondary antibody responses.","volume":"104","author":"Good","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"12","key":"2019111807454423700_B34","doi-asserted-by":"crossref","first-page":"7527","DOI":"10.4049\/jimmunol.1000152","article-title":"Increased B cell proliferation and reduced Ig production in DREAM transgenic mice.","volume":"185","author":"Savignac","year":"2010","journal-title":"J Immunol"},{"issue":"3","key":"2019111807454423700_B35","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1182\/blood-2009-07-235663","article-title":"Histone deacetylases are critical targets of bortezomib-induced cytotoxicity in multiple myeloma.","volume":"116","author":"Kikuchi","year":"2010","journal-title":"Blood"},{"issue":"8","key":"2019111807454423700_B36","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1002\/(SICI)1521-1878(199808)20:8<615::AID-BIES4>3.0.CO;2-H","article-title":"Roles of histone acetyltransferases and deacetylases in gene regulation.","volume":"20","author":"Kuo","year":"1998","journal-title":"Bioessays"},{"issue":"11","key":"2019111807454423700_B37","doi-asserted-by":"crossref","first-page":"5781","DOI":"10.1158\/0008-5472.CAN-05-4186","article-title":"The histone deacetylase inhibitor LBH589 is a potent antimyeloma agent that overcomes drug resistance.","volume":"66","author":"Maiso","year":"2006","journal-title":"Cancer Res"},{"issue":"8","key":"2019111807454423700_B38","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1038\/sj.leu.2404760","article-title":"Apoptosis induced by histone deacetylase inhibitors in leukemic cells is mediated by Bim and Noxa.","volume":"8","author":"Inoue","year":"2007","journal-title":"Leukemia"},{"issue":"4","key":"2019111807454423700_B39","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.drup.2005.06.004","article-title":"Lysosomes and endoplasmic reticulum: targets for improved, selective anticancer therapy.","volume":"8","author":"Linder","year":"2005","journal-title":"Drug Resist Updat"},{"issue":"12","key":"2019111807454423700_B40","doi-asserted-by":"crossref","first-page":"4907","DOI":"10.1182\/blood-2005-08-3531","article-title":"Proteasome inhibitors induce a terminal unfolded protein response in multiple myeloma cells.","volume":"107","author":"Obeng","year":"2006","journal-title":"Blood"},{"issue":"4","key":"2019111807454423700_B41","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.4049\/jimmunol.133.4.1909","article-title":"Human IgE synthesis in vitro by pokeweed mitogen-stimulated human lymphoid cells: verification with a reconfirmed epsilon-specific radioimmunoassay.","volume":"133","author":"Chen","year":"1984","journal-title":"J Immunol"},{"issue":"2","key":"2019111807454423700_B42","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1038\/cdd.2010.100","article-title":"Kr\u00fcppel-like factor KLF9 regulates PPAR\u03b3 transactivation at the middle stage of adipogenesis.","volume":"18","author":"Pei","year":"2011","journal-title":"Cell Death Differ"},{"issue":"4","key":"2019111807454423700_B43","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1093\/oxfordjournals.jbchem.a124224","article-title":"Comparison of DNA-binding properties between BTEB and Sp1.","volume":"114","author":"Sogawa","year":"1993","journal-title":"J Biochem"},{"issue":"1","key":"2019111807454423700_B44","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1002\/stem.561","article-title":"Kr\u00fcppel-like family of transcription factor 9, a differentiation-associated transcription factor, suppresses Notch1 signaling and inhibits glioblastoma-initiating stem cells.","volume":"29","author":"Ying","year":"2011","journal-title":"Stem Cells"},{"issue":"6","key":"2019111807454423700_B45","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1111\/j.1440-1827.2008.02233.x","article-title":"Down-regulation of Kr\u00fcppel-like factor 9 in human colorectal cancer.","volume":"58","author":"Kang","year":"2008","journal-title":"Pathol Int"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/119\/6\/1450\/1358119\/zh800612001450.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/119\/6\/1450\/1358119\/zh800612001450.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,11]],"date-time":"2023-06-11T13:17:49Z","timestamp":1686489469000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/119\/6\/1450\/30208\/KLF9-is-a-novel-transcriptional-regulator-of"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,2,9]]},"references-count":45,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2012,2,9]]}},"URL":"https:\/\/doi.org\/10.1182\/blood-2011-04-346676","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,2,9]]}}}